Why is Read-Gene SA ?
- The company has been able to generate a Return on Capital Employed (avg) of 1.16% signifying low profitability per unit of total capital (equity and debt)
- Poor long term growth as Net Sales has grown by an annual rate of 18.64% and Operating profit at 25.63% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Capital Employed (avg) of 1.16% signifying low profitability per unit of total capital (equity and debt)
- OPERATING CASH FLOW(Y) Lowest at PLN -2.91 MM
- RAW MATERIAL COST(Y) Grown by 338% (YoY)
- CASH AND EQV(HY) Lowest at PLN 10.92 MM
- Over the past year, while the stock has generated a return of -7.25%, its profits have risen by 295%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Read-Gene SA for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At PLN 0.32 MM has Grown at 186.69%
Highest at 38.58%
Highest at 3,313.65 times
Lowest at PLN -2.91 MM
Grown by 338% (YoY
Lowest at PLN 10.92 MM
Highest at 86.11 %
Lowest at PLN -0.35 MM
Lowest at -8.43 %
Lowest at PLN -0.42 MM
Lowest at PLN -0.42 MM
Lowest at PLN -0.04
Here's what is working for Read-Gene SA
Inventory Turnover Ratio
Here's what is not working for Read-Gene SA
Pre-Tax Profit (PLN MM)
Net Profit (PLN MM)
Operating Cash Flows (PLN MM)
Operating Profit (PLN MM)
Operating Profit to Sales
Pre-Tax Profit (PLN MM)
Net Profit (PLN MM)
EPS (PLN)
Cash and Cash Equivalents
Debt-Equity Ratio
Raw Material Cost as a percentage of Sales






